TLDR
- Barclays has upgraded Nike (NKE) to overweight with a new price target of $73, up from $64
- Shares have declined approximately 25% in the last year, trading near decade lows
- North American revenue grew 9% last quarter, though net income dropped 31% year-over-year
- The company’s Q3 FY2026 results are scheduled for March 31, a pivotal moment for recovery prospects
- The investment bank suggests negative sentiment may have reached its peak
The athletic apparel giant has endured a challenging period. Shares have tumbled roughly 25% over the trailing 12 months, placing the iconic brand near valuation levels last seen a decade ago.
The sportswear titan faces pressure from multiple directions simultaneously. Revenue growth has stagnated, competition from both established players and emerging brands intensifies, and leadership transition has injected fresh uncertainty into the equation. Layer in tariff concerns and weakening consumer demand, and the investment thesis becomes increasingly difficult to justify — until recent developments.
Barclays issued an upgrade on Monday, elevating NKE to overweight status while raising the price objective to $73 from its previous $64 level. The analyst firm highlighted operational improvements, strengthening financial metrics, and enhanced management discipline as early indicators of a potential recovery trajectory.
The firm introduced an intriguing concept: that Wall Street sentiment toward the stock may have hit “peak skepticism” — implying the worst may be behind the company.
Strength in North America, But Profitability Remains Under Pressure
The financial picture presents contrasting signals. Nike’s North American operations delivered 9% sales expansion in the latest reporting period, with the region showing 6% growth across the last two quarters combined. This represents genuine progress.
However, profitability hasn’t kept pace. Net income across the most recent two quarters totaled $1.5 billion, representing a 31% decline compared to the prior year period. Escalating expenses are eroding gains made at the revenue level.
This disconnect between top-line growth and bottom-line performance continues to keep many market participants cautious.
March 31 Looms Large
The company’s next critical milestone arrives March 31 with its Q3 FY2026 earnings release. Nike will be measuring performance against relatively weak year-ago comparisons, potentially creating favorable optics for year-over-year metrics.
Whether improved comparisons signal authentic business momentum remains the central question. Certain analysts believe the conditions exist for an earnings surprise. Others cite persistent macroeconomic challenges — consumers gravitating toward budget alternatives, tariff-related pressures — as justification for continued caution.
The Barclays upgrade doesn’t eliminate all concerns. The firm recognizes Nike still carries meaningful risk. However, the upgrade implies that at present valuation levels, much of the negative news may already be reflected in the share price.
The stock currently trades at prices unseen for approximately ten years. Some interpret this as a red flag. Others view it as an opportunity for a rebound play.
Nike reports earnings on March 31.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
